Abstract Strategic Priority 4 (SP4) of the Immunization Agenda 2030 aims to ensure that all
people benefit from recommended immunizations throughout the life-course, integrated with …

Estimating the value of global investment in immunization programs is critical to helping
decision makers plan and mobilize immunization programs and allocate resources required …

Background COVID-19, SARS and MERS are diseases that present an important health
burden worldwide. This situation demands resource allocation to the healthcare system …

Background Decision-makers in middle-income countries need evidence on the cost-
effectiveness of COVID-19 booster doses and oral antivirals to appropriately prioritise these …

Objectives Vaccination has prevented millions of deaths and cases of disease in low-and
middle-income countries (LMICs). During the Decade of Vaccines (2011-2020), international …

Background There were about 138 million new episodes of pneumonia and 0.9 million
deaths globally in 2015. In Uganda, pneumonia was the fourth leading cause of death in …

Objective To explore the prevalence of acute gastroenteritis (AGE) and associated factors in
children and adolescents in the USA from 1999 to 2018 using nationally representative data …

Objective: To identify and assess the current evidence available about the costs of
managing hospitalized pediatric patients diagnosed with Respiratory Syncytial Virus (RSV) …

Disruptions in routine immunization caused by COVID-19 put African countries with large
vaccine-preventable disease burdens at high risk of outbreaks. Abbas et al.(2020) showed …

Background This study estimated the economic cost of treating measles in children under-5
in Bangladesh from the caregiver, government, and societal perspectives. Method We …